Successfully transitioning oral solid dosage (OSD) forms from Phase 1 to Phase 2 clinical studies requires a comprehensive understanding of the challenges and strategies involved.
This webinar offers comprehensive insights into overcoming formulation hurdles and effectively preparing for the transition to Phase 2 clinical studies. Designed to address the critical challenges associated with oral solid dosage (OSD) development, it provides a thorough understanding of the strategies needed to advance drug products successfully through the clinical pipeline.
Dr. Ian Lafferty will explore practical approaches and proven techniques for refining formulations, managing Phase 1 outcomes, and optimizing development timelines. Real-world examples bring clarity to these complex processes, enabling you to navigate common obstacles with confidence.
Whether you’re refining an OSD formulation or preparing for regulatory milestones, this webinar highlights the key factors influencing clinical success. Gain actionable solutions to streamline your development process, minimize risks, and ensure your drug product is poised for progression into the next clinical phase.
Most registrants disappear after the session ends. We help you
open the right doors before, during, and after the webinar.
<span>By ticking this box, you consent to receiving communications from Upperton related to this topic and other products or services within their portfolio</span>